Skip to main content
Clinical Trials/ISRCTN84389045
ISRCTN84389045Completed未知

Reduction in the incidence of gestational diabetes mellitus (GDM) with MedDiet/Lifestyle and its impact on genetic and epigenetic pattern expression in pregnant women and their offspring

The Health Research Institute at the Hospital Clinico San Carlos (Spain)0 sites697 target enrollmentStarted: December 4, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
697

Study Overview

Brief Summary

  1. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/29049303 (added 24/01/2019) 2. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/30554220 (added 31/03/2020)

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
Female

Inclusion Criteria

  • 1. Women aged over 18
  • 2. With normal fasting glucose values (< 92 mg/dl) in the 1st gestational assessment (8-12 GWs)
  • 3. Who sign the informed consent
  • Added 30/08/2017: 4. Having attended GDM screening at 24-28 gestational weeks
  • Added 26/01/2018: 5. Who did not develop GDM

Exclusion Criteria

  • 1. Women with fasting glucose levels >92 mg/dl in the 1st gestational assessment (8-12 GWs)
  • 2. Multiple pregnancy
  • 3. Nut allergy or any other medical condition
  • 4. Ongoing medication
  • 5. Significant disability that would prevent the participant from complying with trial consent, treatment and follow-up procedures or potentially jeopardize her medical care
  • Added 26/01/2018: 6. GDM diagnosis

Investigators

Sponsor
The Health Research Institute at the Hospital Clinico San Carlos (Spain)

Similar Trials